ZENTALIS PHARMACEUTICALS INC (ZNTL) Stock Income Statement
NASDAQ:ZNTL - Nasdaq - US98943L1070 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.86M | 67.42M | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 0.00 | 28.00K | 114.00K | 310.00K | 7.37M | |||
| Operating Expenses | 226.23M | 254.88M | 248.94M | 227.29M | 207.74M | |||
| Research and Development | 144.28M | 167.77M | 189.59M | 172.73M | 166.80M | |||
| Selling, General, and Administrative Expenses | 81.95M | 87.11M | 59.35M | 54.55M | 40.94M | |||
| Operating Income | -199.37M | -187.46M | -248.94M | -227.29M | -207.74M | |||
| Interest Income/Expense | -12.10M | 25.50M | 22.62M | 5.99M | 400.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -12.68M | -3.74M | -50.57M | 0.00 | 42.78M | |||
| Income Before Taxes | -224.15M | -165.69M | -276.89M | -221.30M | -164.56M | |||
| Income Tax | 34.00K | 177.00K | -601.00K | -470.00K | -300.00K | |||
| Net Income | -224.19M | -165.84M | -292.19M | -236.81M | -158.73M | |||
| EBITDA | -198.14M | -186.17M | -247.55M | -225.86M | -207.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.15 | -2.33 | -4.47 | -4.48 | -3.72 | |||
| Non GAAP EPS | -2.98 | -2.28 | -4.64 | -4.53 | -4.94 | |||
| Statistics | ||||||||
| Profit Margin | -834.49% | -245.96% | N/A | N/A | N/A | |||
| Operating Profit Margin | -742.11% | -278.02% | N/A | N/A | N/A | |||
All data in USD